CIPLA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Sep-18* | 3 Jun-19* | 3 Sep-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 40,119 | 39,890 | 43,958 | 10.2% | 9.6% |
Other income | Rs m | 1,326 | 784 | 1,005 | 28.3% | -24.2% |
Turnover | Rs m | 41,445 | 40,674 | 44,963 | 10.5% | 8.5% |
Expenses | Rs m | 33,097 | 30,844 | 34,863 | 13.0% | 5.3% |
Gross profit | Rs m | 7,022 | 9,046 | 9,095 | 0.5% | 29.5% |
Depreciation | Rs m | 2,819 | 2,680 | 2,830 | 5.6% | 0.4% |
Interest | Rs m | 444 | 521 | 461 | -11.6% | 3.8% |
Profit before tax | Rs m | 5,085 | 6,629 | 6,810 | 2.7% | 33.9% |
Tax | Rs m | 1,424 | 1,922 | 2,006 | 4.3% | 40.8% |
Profit after tax | Rs m | 3,661 | 4,707 | 4,804 | 2.1% | 31.2% |
Gross profit margin | % | 17.5 | 22.7 | 20.7 | ||
Effective tax rate | % | 28.0 | 29.0 | 29.4 | ||
Net profit margin | % | 8.8 | 11.6 | 10.7 |
To see how CIPLA has performed over the last eight quarters,please visit here.
Free Guide: Find the Next Crorepati Stock in this Futuristic Industry
Over the last one year,CIPLA share price has moved down from Rs 520.1 to Rs 450.4, registering a Loss of Rs 69.7 or around 13.4%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,939.9 (up 0.0%). Over the last one year it has moved down from 14,231.1 to 12,939.9, a gain of 1,291 points (down 9.1%).
Overall, the S&P BSE SENSEX is up 14.4% over the year.
At the current price of Rs 450.4, the price to earnings (P/E) ratio of CIPLA stands at 22.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.4 times.
| |
Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.
For the quarter ended June 2019, CIPLA has posted a net profit of Rs 5 bn (up 5.6% YoY). Sales on the other hand came in at Rs 40 bn (up 1.3% YoY). Read on for a complete analysis of CIPLA's quarterly results.
For the quarter ended March 2019, CIPLA has posted a net profit of Rs 4 bn (up 144.0% YoY). Sales on the other hand came in at Rs 44 bn (up 19.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.
Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsWhat to do after every trade.
What we can learn from one of the greatest traders to have ever lived.
This corner of the market could provide more returns than blue chips in 2020.
Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.
2019 will be remembered as the year of great money-making IPOs...
More
| |
Equitymaster requests your view! Post a comment on "CIPLA Announces Quarterly Results (2QFY20); Net Profit Up 31.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!